ConductScience.org, home

Paper26344344

Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens.

Sattentau QJ. Vaccines (Basel), 2013. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens. Papers, record 26344344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344344

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2025-05-29
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sattentau QJQuentin J

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G0000635Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121938063Vaccinology: precisely tuned antibodies nab HIV.Nature2011https://conductscience.org/library/papers/21938063PubMed
212970440Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.J Virol2003https://conductscience.org/library/papers/12970440PubMed
317598812Humoral immunity to HIV-1: neutralization and beyond.J Intern Med2007https://conductscience.org/library/papers/17598812PubMed
424068931A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.PLoS Pathog2013https://conductscience.org/library/papers/24068931PubMed
520705840AIDS/HIV. A boost for HIV vaccine design.Science2010https://conductscience.org/library/papers/20705840PubMed
619965434Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.Science2009https://conductscience.org/library/papers/19965434PubMed
712646921Antibody neutralization and escape by HIV-1.Nature2003https://conductscience.org/library/papers/12646921PubMed
821471242Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.J Virol2011https://conductscience.org/library/papers/21471242PubMed
910623724
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
J Virol2000https://conductscience.org/library/papers/10623724PubMed
1020826338Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope.Structure2010https://conductscience.org/library/papers/20826338PubMed
1123552894HIV: Roadmaps to a vaccine.Nature2013https://conductscience.org/library/papers/23552894PubMed
127543586Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.J Virol1995https://conductscience.org/library/papers/7543586PubMed
1315932765The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.Virology2005https://conductscience.org/library/papers/15932765PubMed
1419372883Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination.Curr Opin HIV AIDS2007https://conductscience.org/library/papers/19372883PubMed
158057475Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.J Virol1994https://conductscience.org/library/papers/8057475PubMed
1620192810The role of antibodies in HIV vaccines.Annu Rev Immunol2010https://conductscience.org/library/papers/20192810PubMed
1723414404Developments in virus-like particle-based vaccines for HIV.Expert Rev Vaccines2013https://conductscience.org/library/papers/23414404PubMed
1820882016Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.Nature2010https://conductscience.org/library/papers/20882016PubMed
1923735804The HIV-1-containing macrophage compartment: a perfect cellular niche?Trends Microbiol2013https://conductscience.org/library/papers/23735804PubMed
2021849977Broad neutralization coverage of HIV by multiple highly potent antibodies.Nature2011https://conductscience.org/library/papers/21849977PubMed

See all 101 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
31569763Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help.Nanomaterials (Basel)2019https://conductscience.org/library/papers/31569763PubMed
31111416Overcoming Challenges in Structural Characterization of HIV-1 Envelope Glycoprotein by LC-MS/MS.J Am Soc Mass Spectrom2019https://conductscience.org/library/papers/31111416PubMed
30969970Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.PLoS One2019https://conductscience.org/library/papers/30969970PubMed
30928513Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach.J Biomed Inform2019https://conductscience.org/library/papers/30928513PubMed
28381572Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes.J Virol2017https://conductscience.org/library/papers/28381572PubMed
28149882Simian immunodeficiency virus confounds T follicular helper T cells and the germinal centre.Ann Transl Med2016https://conductscience.org/library/papers/28149882PubMed
27996375Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env.MAbs2017https://conductscience.org/library/papers/27996375PubMed
27512064Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.J Virol2016https://conductscience.org/library/papers/27512064PubMed
27449907Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody.Mol Immunol2016https://conductscience.org/library/papers/27449907PubMed
25848984A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses.AIDS Res Hum Retroviruses2015https://conductscience.org/library/papers/25848984PubMed
25190279Mathematical model of multivalent virus-antibody complex formation in humans following acute and chronic HIV infections.J Math Biol2015https://conductscience.org/library/papers/25190279PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26344344

GET https://conductscience.org/api/papers/v1/26344344/references?page=2